Surging demand for Korean pharma in 2023 ahead of CPHI Korea
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Medica Superspecialty Hospital becomes the first private hospital in Eastern India to collaborate with UNICEF for breastfeeding workshop
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
The company has secured 506 marketing approvals for its oncology products across 76 countries.
Marks the World Head & Neck Cancer Day at the OCTF Conference
This transformation will enable GE HealthCare to build a strong foundation for business growth
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Advances clinical research capabilities with leading regulatory grade registries platform
However, PAT growth will be lower than operating profit growth mainly due to brand amortization expenditure on account of acquisition.
Subscribe To Our Newsletter & Stay Updated